Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2008-01-08
2008-01-08
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S458000, C424S459000, C424S462000, C424S468000, C424S470000, C424S474000, C424S482000, C424S489000, C424S497000
Reexamination Certificate
active
07316818
ABSTRACT:
This invention comprises pharmaceutical compositions for administering a polycyclic, aromatic, antioxidant or anti-inflammatory compound to an animal. Particularly provided are proliposomal compositions that are advantageously used to deliver polycyclic, aromatic, antioxidant or anti-inflammatory compounds to the gastrointestinal tract after oral administration.
REFERENCES:
patent: 4302440 (1981-11-01), John et al.
patent: 4615885 (1986-10-01), Nakagame et al.
patent: 4687762 (1987-08-01), Fukushima et al.
patent: 4744989 (1988-05-01), Payne et al.
patent: 4857337 (1989-08-01), Miller et al.
patent: 4921757 (1990-05-01), Wheatley et al.
patent: 4963526 (1990-10-01), Ecanow et al.
patent: 5004611 (1991-04-01), Leigh
patent: 5043165 (1991-08-01), Radhakrishnan
patent: 5053217 (1991-10-01), Lehigh
patent: 5141674 (1992-08-01), Leigh
patent: 5223263 (1993-06-01), Hostetler et al.
patent: 5466468 (1995-11-01), Schneider et al.
patent: 5484809 (1996-01-01), Hostetler et al.
patent: 5580571 (1996-12-01), Hostetler et al.
patent: 5595756 (1997-01-01), Bally et al.
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 5626869 (1997-05-01), Nyqvist et al.
patent: 5635206 (1997-06-01), Ganter et al.
patent: 5654314 (1997-08-01), Banholzer et al.
patent: 5665379 (1997-09-01), Herslof
patent: 5738868 (1998-04-01), Shinkarenko
patent: 5744461 (1998-04-01), Hostetler
patent: 5744592 (1998-04-01), Hostetler et al.
patent: 5756116 (1998-05-01), Hostetler et al.
patent: 5762904 (1998-06-01), Okada et al.
patent: 5770738 (1998-06-01), Banholzer et al.
patent: 5843509 (1998-12-01), Calvo Salve et al.
patent: 5955451 (1999-09-01), Lichtenberger et al.
patent: 5958450 (1999-09-01), Tashiro et al.
patent: 6015576 (2000-01-01), See et al.
patent: 6060082 (2000-05-01), Chen et al.
patent: 6117449 (2000-09-01), See et al.
patent: 6207185 (2001-03-01), See et al.
patent: 6207190 (2001-03-01), Richardson et al.
patent: 6231888 (2001-05-01), Lerner et al.
patent: 6824790 (2004-11-01), Yatvin
patent: 350287 (1990-01-01), None
patent: 0 736 299 (1996-10-01), None
patent: 0855 179 (1998-07-01), None
patent: 0855179 (1998-07-01), None
patent: 2 581 543 (1986-07-01), None
patent: WO 8902733 (1989-04-01), None
patent: WO94 28876 (1994-12-01), None
patent: WO 9503035 (1995-02-01), None
patent: WO97 12580 (1997-04-01), None
patent: WO 9300910 (1998-01-01), None
patent: WO 00 28989 (2000-05-01), None
patent: WO 02 13782 (2002-02-01), None
Payne et al., “Prolipsomes: A Novel Solution to an Old Problem,Journal of Pharmaceutical Sciences”, 75(4)325-6 (Apr. 1, 1986).
Kumar et al., Formulation characterization an in vitro release of Glyburide from Proliposomal beads STN Database accession No. 2001082693 XP002184270.
Katare et al., “Proliposomes of Indomethacin for Oral Administration”, Journal of Microencapsulation, Taylor and Francis Inc. London, GB, 8(1)1-7 (1991).
Katare et al., “Effecvescent Granule Based Proliposomes of Ibuprofen”, Journal of Microencapsulation,Taylor and Fransis Inc. London, GB, 7(4) 355-62 (Oct. 1990).
Oku N. et al., “Effect of Freeze-Thawing on Phospholipid/Surfactant Mixed Bilayers”Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan. Tokyo, JP44(10)1928-30 (Oct. 1, 1996).
Alvarez-Dominquez et al., “Role of Complement Component C1q in Phagoctosis of Listeria monocytogenes by Murine Macrophage-Like Lines”,Infect Immun.61:3664-72 (1993).
Bignami et al., “N-(-4'-Hydroxyphenylacetyl) palytoxin: A Palytoxin Prodrug That Can Be Activated by a Monoclonal Antibody-Penicellin G Amidase Conjugate”, 1992Cancer Res52:5759-64 (1992).
Embretson et al., “Massive covert infection of helper T lymphohocytes and macrophages by HIV during the incubation period of AIDS”,Nature362:359-62 (1993).
Gregoriadis et al., “Engineering liposomes for drug delivery: progress and problems”,Trends in Biotechnology13:527-37 (1995).
Kanno et al., “Aleutian Milk Disease Parvovirus Infection of Mink Peritoneal Macrophages and Human Macrophage Cell Lines”,J. Virol.67:2075-82 (1993).
Kanno et al., “Infection of Aleutian Mink Disease Parvovirus Transcripts in Macrophages of Infected Adult Mink”.J. Virol66:5305-5312 (1992).
Kulkarni et al. “Protamine-induced Aggregation of Unilamellar Lipososomes” Pharmaceutical Science 1:359-362 (1995).
Maciejewski et al., “Infection of Mononucleated Phagocytes with Human Cytomegalovirus”,Virol195:327-336 (1993).
Manusama et al., “Tumor Necoris Factor-Alpha in Isolated Perfusion Systems in the Treatment of Cancer: The Rotterdam Preclinical-Clinical Program”, Semin. Surg. Oncol. 14:232-237 (1998).
Meltzer & Gendelma et al., “Mononuclear Phagocytes as Targets, Tissue Reservoirs, and immunoregulatory Cells in Human Immunodeficiency Virus Disease”, Curr. Top. Microbiol Immunol. 181:239-63 (1992).
Mickisch et al., “Gene Therapy on Renal-Cell Carcinoma: magic bullet of tragic insanity”, World J. Urology 13:178-185 (1995).
Rahman et al., “Differential Uptake of Liposomes Varying in Size and Lipid Composition by Parentchymal and Kupffer Cells of Mouse Liver”, 31:2061-71 (1982).
Sierra-Honigman et al., “Borna disease virus in peripheral blood mononuclear and bone marrow cells of neonatally and chronically infected rats”, J. Neuroimmunal 45:31-36 (1993).
Storm and Crommetin “Colloidal Systems for Tumor Targeting” Hybridoma 16(1) 1997.
Sturgill-Koszycki et al., “Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPase”, Science 263:678-681 (1994).
Yang et al., “Gene Therapy for Central Nervous System Injury: The Use of Cationic Liposomes: An Invited Review”, J. Neurotrauma 14:281-297 (1997).
Kishore Gollamudi S.
McDonnell & Boehnen Hulbert & Berghoff
Oradel Medical Ltd.
LandOfFree
Liposome drug delivery of polycyclic, aromatic, antioxidant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposome drug delivery of polycyclic, aromatic, antioxidant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome drug delivery of polycyclic, aromatic, antioxidant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2770269